한글목차

세계 라임병 진단 시장의 미래는 병원 및 클리닉, 병리 검사실, 제약 산업, 임상 연구 기관 등 다양한 시장에서의 기회로 인해 유망합니다. 세계 라임병 진단 시장은 2025년부터 2031년까지 3.6%의 CAGR로 2031년까지 약 19억 달러에 달할 것으로 예상됩니다. 이 시장의 주요 촉진요인은 정부의 의료 시설 확충, 라임병의 새로운 진단 도구 개발, 주요 기업들의 라임병 진단 연구 및 개발에 대한 관심 증가 등이 있습니다.

• Lucintel의 예측에 따르면, 진단 검사 카테고리 중 혈청학적 검사는 감염자의 체내에서 항원에 반응하여 생성되는 항체 검출에 초점을 맞추고 있기 때문에 예측 기간 동안 가장 큰 부문을 차지할 것으로 예상됩니다.
• 지역별로는 의료비 상승과 신제품 출시로 인해 북미가 예측 기간 동안 가장 높은 성장세를 보일 것으로 예상됩니다.

라임병 진단 시장에서의 전략적 성장 기회

라임병 진단 시장의 전략적 성장 기회는 다양한 주요 응용 분야에서 나타나고 있습니다.

• 조기발견 기술 : 라임병을 조기에 정확하게 검출할 수 있는 검사의 개발로 환자의 예후를 크게 개선할 수 있습니다.
• PoC(Point-of-Care) 검사 : 원격지나 의료 접근성이 낮은 지역에서의 접근성을 높이기 위해 PoC(Point-of-Care) 검사의 선택권을 확대하는 것이 성장의 기회입니다.
• 디지털 헬스와의 통합 : 라임병의 진단과 관리에 디지털 헬스 툴과 원격의료를 활용함으로써 환자 치료를 강화할 수 있습니다.
• 세계 시장 확대 : 진드기 매개 질환에 대한 인식이 높아지고 있는 신흥시장 진출은 큰 성장 잠재력을 가지고 있습니다.
• 비용 효율적인 솔루션 : 다양한 의료 시스템에 적합한 합리적인 가격의 진단 검사를 개발하여 새로운 시장 부문을 확보할 수 있습니다.
• 연구 협력 강화 : 전 세계 연구기관과 협력하여 진단법 및 진단 기술을 발전시킴으로써 혁신을 촉진할 수 있습니다.

라임병 진단제 시장의 전략적 성장 기회는 조기 발견, PoC 검사, 세계 진출의 발전으로 인해 다양한 시장 개척의 길을 제공하고 있습니다.

라임병 진단 시장 활성화 요인 및 과제

라임병 진단 시장은 성장과 개척에 영향을 미치는 다양한 촉진요인 및 과제에 의해 형성되고 있습니다.

라임병 진단 시장을 이끄는 요인은 다음과 같습니다:

• 인지도 향상 : 라임병과 그 증상에 대한 인식이 높아짐에 따라 진단 검사에 대한 수요가 증가하고 있습니다.
• 규제 당국의 지원 : 좋은 규제 환경과 업데이트는 새로운 진단 기술의 도입을 촉진하고 있습니다.
• 연구 자금 : 연구개발에 대한 투자 증가로 첨단 진단법 개발이 촉진되고 있습니다.
• 의료 인프라 : 의료 인프라 및 진단 센터의 개선으로 검사 능력이 확대되고 있습니다.
• 세계 진출 : 인지도 향상과 의료에 대한 투자로 새로운 시장 진출이 성장 기회를 가져다 줄 것입니다.

라임병 진단 시장의 과제는 다음과 같습니다:

• 높은 비용 : 특히 자원이 부족한 환경에서는 고급 진단 검사에 소요되는 비용이 그 활용을 제한할 수 있습니다.
• 진단의 복잡성 : 다른 질환과의 감별을 포함하여 라임병 진단의 복잡성은 어렵습니다.
• 규제적 장애물 : 새로운 진단 기술에 대한 규제 요건과 인허가를 받는 데는 시간이 걸립니다.
• 시장 경쟁 : 진단약 제조업체 간의 치열한 경쟁은 시장 점유율과 수익성에 영향을 미칠 수 있습니다.
• 표준화 부족 : 지역마다 진단 기준과 실시 방법이 달라 결과의 일관성에 영향을 미칠 수 있습니다.
• 지역에 따라 인지도가 낮다 : 지역에 따라 라임병에 대한 인식과 이해가 부족하여 시장 성장에 걸림돌이 될 수 있습니다.

라임병 진단 시장은 기술 발전과 인지도 향상에 힘입어 성장하고 있지만, 높은 비용과 규제 장벽이라는 도전에 직면해 있어 지속가능한 성장과 접근성을 보장하기 위한 전략적 접근이 필요합니다.

목차

제1장 주요 요약

제2장 세계의 라임병 진단 시장 : 시장 역학

• 소개, 배경, 분류
• 공급망
• 업계 성장 촉진요인과 과제

제3장 시장 동향과 예측 분석(2019-2031년)

• 거시경제 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 라임병 진단 시장 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 라임병 진단 시장 : 진단 검사별
  • 혈청학적 검사
  • 핵산 증폭 기술
  • 소변 항원 검사
  • 림프구 형질전환 시험
  • 면역형광 염색
  • PCR 분석
  • 기타
• 세계의 라임병 진단 시장 : 기술별
  • 분자진단
  • 뇌MRI
  • 척수천자
  • 심장초음파 검사
  • 심전도
  • 단클론항체
  • 유세포 분석
  • 겔 마이크로 드롭렛
  • 기타
• 세계의 라임병 진단 시장 : 최종 용도별
  • 병원·클리닉
  • 병리 검사실
  • 제약 업계
  • 임상 연구기관
  • 기타

제4장 지역별 시장 동향과 예측 분석(2019-2031년)

• 세계의 라임병 진단 시장 : 지역별
• 북미의 라임병 진단 시장
• 유럽의 라임병 진단 시장
• 아시아태평양의 라임병 진단 시장
• 기타 지역의 라임병 진단 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략 분석

• 성장 기회 분석
  • 세계의 라임병 진단 시장 성장 기회 : 진단 검사별
  • 세계의 라임병 진단 시장 성장 기회 : 기술별
  • 세계의 라임병 진단 시장 성장 기회 : 최종 용도별
  • 세계의 라임병 진단 시장 성장 기회 : 지역별
• 세계의 라임병 진단 시장 최신 동향
• 전략적 분석
  • 신제품 개발
  • 세계의 라임병 진단 시장 생산능력 확대
  • 세계의 라임병 진단 시장 기업 인수합병(M&A), 합작투자
  • 인증과 라이선싱

제7장 주요 기업 개요

• LEDLink Optics
• Carclo Optics
• Auer Lighting
• LEDIL Oy
• FRAEN
• GAGGIONE
• Bicom Optics
• Darkoo Optics
• Alere
• Boulder Diagnostics

영문목차

The future of the global lyme disease diagnostic market looks promising with opportunities in the hospital & clinic, pathology lab, pharmaceutical industry, and clinical research institute markets. The global lyme disease diagnostic market is expected to reach an estimated $1.9 billion by 2031 with a CAGR of 3.6% from 2025 to 2031. The major drivers for this market are government emphasis on enhancing healthcare facilities, the development of novel diagnostic tools for Lyme disease, and the increased interest of key players in Lyme disease diagnosis R&D.

• Lucintel forecasts that, within the diagnostic test category, serological tests will remain the largest segment over the forecast period because they focus on detecting antibodies produced in the body of an infected individual in response to antigens.
• In terms of regions, North America is expected to witness the highest growth over the forecast period due to rising healthcare costs and the introduction of new products.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Lyme Disease Diagnostic Market

Emerging trends in the Lyme disease diagnostic market highlight advancements in technology and evolving clinical practices.

• Advanced Diagnostic Technologies: The development of more sensitive and specific tests, including PCR and next-generation sequencing, is enhancing diagnostic accuracy.
• Point-of-Care Testing: Innovations in point-of-care testing are improving accessibility and convenience for patients and healthcare providers.
• Integration with Digital Health: Digital health tools and telemedicine are being integrated into diagnostic processes to improve disease management.
• Standardization of Diagnostic Criteria: Efforts are underway to standardize diagnostic criteria and guidelines to ensure consistency across regions.
• Increased Research Funding: Growing investment in research is driving the development of new diagnostic methods and technologies.
• Public Awareness Campaigns: Enhanced public health campaigns are raising awareness about Lyme disease and its symptoms, leading to earlier diagnosis.

Emerging trends in the Lyme disease diagnostic market reflect advancements in technology, an increased focus on point-of-care testing, and efforts to standardize diagnostic criteria, signaling a more accurate and accessible approach to Lyme disease management.

Recent Developments in the Lyme Disease Diagnostic Market

Recent developments in the Lyme disease diagnostic market demonstrate significant progress and innovation.

• Introduction of New Tests: The market has seen the launch of improved diagnostic tests, including advanced PCR assays and high-resolution serological tests.
• Regulatory Updates: Regulatory agencies are updating guidelines to incorporate new diagnostic technologies and improve accuracy.
• Enhanced Research Initiatives: Increased funding and research are leading to the development of novel diagnostic methods and technologies.
• Expansion of Diagnostic Centers: The establishment of specialized diagnostic centers in endemic regions is improving testing accessibility.
• Increased Collaboration: Partnerships between research institutions and industry players are driving innovation in diagnostic technologies.
• Focus on Rapid Testing: The development of rapid diagnostic tests is making it easier to diagnose Lyme disease promptly and accurately.

Recent developments in the Lyme disease diagnostic market highlight advancements in testing technologies, regulatory updates, and increased research, contributing to more accurate and accessible diagnostics.

Strategic Growth Opportunities for Lyme Disease Diagnostic Market

Strategic growth opportunities in the Lyme disease diagnostic market are emerging across various key applications.

• Early Detection Technologies: Developing tests that offer early and accurate detection of Lyme disease can significantly improve patient outcomes.
• Point-of-Care Testing: Expanding point-of-care testing options to increase accessibility in remote and underserved areas presents a growth opportunity.
• Integration with Digital Health: Leveraging digital health tools and telemedicine for Lyme disease diagnostics and management can enhance patient care.
• Global Market Expansion: Entering emerging markets with increasing awareness of tick-borne diseases offers significant growth potential.
• Cost-Effective Solutions: Developing affordable diagnostic tests suitable for diverse healthcare systems can capture new market segments.
• Enhanced Research Collaboration: Collaborating with global research institutions to advance diagnostic methods and technologies can drive innovation.

Strategic growth opportunities in the Lyme disease diagnostic market are driven by advancements in early detection, point-of-care testing, and global expansion, offering diverse avenues for market development.

Lyme Disease Diagnostic Market Driver and Challenges

The Lyme disease diagnostic market is shaped by various drivers and challenges influencing its growth and development.

The factors responsible for driving the Lyme disease diagnostic market include:

• Increased Awareness: Growing awareness about Lyme disease and its symptoms is leading to higher demand for diagnostic tests.
• Regulatory Support: Favorable regulatory environments and updates are facilitating the introduction of new diagnostic technologies.
• Research Funding: Increased investment in research is driving the development of advanced diagnostic methods.
• Healthcare Infrastructure: Improvements in healthcare infrastructure and diagnostic centers are expanding testing capabilities.
• Global Expansion: Expanding into new markets with rising awareness and healthcare investments presents growth opportunities.

Challenges in the Lyme disease diagnostic market include:

• High Costs: The cost of advanced diagnostic tests can limit accessibility, particularly in low-resource settings.
• Diagnostic Complexity: The complexity of Lyme disease diagnostics, including differentiation from other diseases, can be challenging.
• Regulatory Hurdles: Navigating regulatory requirements and approvals for new diagnostic technologies can be time-consuming.
• Market Competition: Intense competition among diagnostic manufacturers can impact market share and profitability.
• Lack of Standardization: Variability in diagnostic criteria and practices across regions can affect the consistency of results.
• Limited Awareness in Some Regions: Inadequate awareness and understanding of Lyme disease in certain areas can hinder market growth.

The Lyme disease diagnostic market is driven by technological advancements and increased awareness but faces challenges such as high costs and regulatory hurdles, requiring strategic approaches to ensure sustained growth and accessibility.

List of Lyme Disease Diagnostic Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies lyme disease diagnostic companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the lyme disease diagnostic companies profiled in this report include-

• Abbott Laboratories
• Qiagen
• Biosystems
• Bio-Rad Laboratories
• Immunetics
• Roche Diagnostics
• T2 Biosystems
• Graphene Frontiers
• Alere
• Boulder Diagnostics

Lyme Disease Diagnostic by Segment

The study includes a forecast for the global lyme disease diagnostic market by diagnostic test, technology, end use, and region.

Lyme Disease Diagnostic Market by Diagnostic Test [Analysis by Value from 2019 to 2031]:

• Serological Test
• Nucleic Acid Amplification Techniques
• Urine Antigen Tests
• Lymphocytic Transformation Test
• Immunofluorescent Staining
• PCR Analysis
• Others

Lyme Disease Diagnostic Market by Technology [Analysis by Value from 2019 to 2031]:

• Molecular Diagnostics
• Brain MRI
• Spinal Tap
• Echocardiogram
• Electrocardiogram
• Monoclonal Antibodies
• Flow Cytometry
• Gel Microdroplets
• Others

Lyme Disease Diagnostic Market by End Use [Analysis by Value from 2019 to 2031]:

• Hospitals & Clinics
• Pathology labs
• Pharmaceutical Industries
• Clinical Research Institute
• Others

Lyme Disease Diagnostic Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Lyme Disease Diagnostic Market

Major players in the market are expanding their operations and forming strategic partnerships to strengthen their positions. Below are recent developments by major Lyme disease diagnostic producers in key regions: the USA, China, India, and Japan.

• USA: In the U.S., the Lyme disease diagnostic market is evolving with advances in testing technologies and increased awareness. Recent developments include the introduction of more sensitive and specific diagnostic tests, such as improved PCR assays and serological tests that offer better early detection and differentiation from other tick-borne diseases. The CDC has been updating its guidelines to reflect new diagnostic methods and improve diagnostic accuracy. Additionally, there is a growing emphasis on developing point-of-care tests and integrating digital health tools to enhance disease management. Increased funding for research and public health campaigns is also contributing to market growth.
• China: China's Lyme disease diagnostic market is expanding with improvements in testing technology and increased awareness of tick-borne diseases. Recent developments include the adoption of more advanced diagnostic tests and the establishment of specialized diagnostic centers in endemic regions. China is also investing in research to develop new diagnostic methods and enhance existing ones. Government health initiatives are focusing on improving disease surveillance and diagnostic capabilities. Additionally, there is a growing collaboration between Chinese and international research institutions to advance Lyme disease diagnostics and control measures.
• India: In India, the Lyme disease diagnostic market is in the early stages of development, with recent advancements focusing on increasing awareness and improving diagnostic capabilities. Efforts are being made to introduce more reliable diagnostic tests and integrate them into public health programs. Research institutions are working on developing cost-effective diagnostic solutions suitable for the Indian healthcare system. Increased collaboration with international organizations and funding for research are helping to improve diagnostic infrastructure and support the development of better testing methods. Public health campaigns are also aiming to raise awareness about Lyme disease and its diagnosis.
• Japan: Japan's Lyme disease diagnostic market is seeing gradual progress with the introduction of advanced diagnostic technologies and increased research activities. Recent developments include the implementation of more sensitive diagnostic tests, such as enhanced serological and molecular assays. The Japanese government is supporting research initiatives to improve diagnostic accuracy and early detection. There is also an emphasis on educating healthcare professionals and enhancing diagnostic capabilities in endemic areas. Collaborative efforts between Japanese research institutions and international organizations are contributing to the advancement of Lyme disease diagnostics.

Features of the Global Lyme Disease Diagnostic Market

Market Size Estimates: Lyme disease diagnostic market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Lyme disease diagnostic market size by diagnostic test, technology, end use, and region in terms of value ($B).

Regional Analysis: Lyme disease diagnostic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different diagnostic test, technology, end use, and regions for the lyme disease diagnostic market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the lyme disease diagnostic market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the lyme disease diagnostic market by diagnostic test (serological test, nucleic acid amplification techniques, urine antigen tests, lymphocytic transformation test, immunofluorescent staining, PCR Analysis, and others), technology (molecular diagnostics, brain MRI, spinal tap, echocardiogram, electrocardiogram, monoclonal antibodies, flow cytometry, gel microdroplets, and others), end use (hospitals & clinics, pathology labs, pharmaceutical industries, clinical research institute, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Lyme Disease Diagnostic Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Lyme Disease Diagnostic Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Lyme Disease Diagnostic Market by Diagnostic Test
  • 3.3.1: Serological Test
  • 3.3.2: Nucleic Acid Amplification Techniques
  • 3.3.3: Urine Antigen Tests
  • 3.3.4: Lymphocytic Transformation Test
  • 3.3.5: Immunofluorescent Staining
  • 3.3.6: PCR Analysis
  • 3.3.7: Others
• 3.4: Global Lyme Disease Diagnostic Market by Technology
  • 3.4.1: Molecular Diagnostics
  • 3.4.2: Brain MRI
  • 3.4.3: Spinal Tap
  • 3.4.4: Echocardiogram
  • 3.4.5: Electrocardiogram
  • 3.4.6: Monoclonal Antibodies
  • 3.4.7: Flow Cytometry
  • 3.4.8: Gel Microdroplets
  • 3.4.9: Others
• 3.5: Global Lyme Disease Diagnostic Market by End Use
  • 3.5.1: Hospitals & Clinics
  • 3.5.2: Pathology labs
  • 3.5.3: Pharmaceutical Industries
  • 3.5.4: Clinical Research Institute
  • 3.5.5: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Lyme Disease Diagnostic Market by Region
• 4.2: North American Lyme Disease Diagnostic Market
  • 4.2.1: North American Market by Diagnostic Test: Serological Test, Nucleic Acid Amplification Techniques, Urine Antigen Tests, Lymphocytic Transformation Test, Immunofluorescent Staining, PCR Analysis, and Others
  • 4.2.2: North American Market by End Use: Hospitals & Clinics, Pathology labs, Pharmaceutical Industries, Clinical Research Institute , and Others
• 4.3: European Lyme Disease Diagnostic Market
  • 4.3.1: European Market by Diagnostic Test: Serological Test, Nucleic Acid Amplification Techniques, Urine Antigen Tests, Lymphocytic Transformation Test, Immunofluorescent Staining, PCR Analysis, and Others
  • 4.3.2: European Market by End Use: Hospitals & Clinics, Pathology labs, Pharmaceutical Industries, Clinical Research Institute , and Others
• 4.4: APAC Lyme Disease Diagnostic Market
  • 4.4.1: APAC Market by Diagnostic Test: Serological Test, Nucleic Acid Amplification Techniques, Urine Antigen Tests, Lymphocytic Transformation Test, Immunofluorescent Staining, PCR Analysis, and Others
  • 4.4.2: APAC Market by End Use: Hospitals & Clinics, Pathology labs, Pharmaceutical Industries, Clinical Research Institute , and Others
• 4.5: ROW Lyme Disease Diagnostic Market
  • 4.5.1: ROW Market by Diagnostic Test: Serological Test, Nucleic Acid Amplification Techniques, Urine Antigen Tests, Lymphocytic Transformation Test, Immunofluorescent Staining, PCR Analysis, and Others
  • 4.5.2: ROW Market by End Use: Hospitals & Clinics, Pathology labs, Pharmaceutical Industries, Clinical Research Institute , and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Lyme Disease Diagnostic Market by Diagnostic Test
  • 6.1.2: Growth Opportunities for the Global Lyme Disease Diagnostic Market by Technology
  • 6.1.3: Growth Opportunities for the Global Lyme Disease Diagnostic Market by End Use
  • 6.1.4: Growth Opportunities for the Global Lyme Disease Diagnostic Market by Region
• 6.2: Emerging Trends in the Global Lyme Disease Diagnostic Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Lyme Disease Diagnostic Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Lyme Disease Diagnostic Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: LEDLink Optics
• 7.2: Carclo Optics
• 7.3: Auer Lighting
• 7.4: LEDIL Oy
• 7.5: FRAEN
• 7.6: GAGGIONE
• 7.7: Bicom Optics
• 7.8: Darkoo Optics
• 7.9: Alere
• 7.10: Boulder Diagnostics